drugset / Trial / NCT00004060

Chemotherapy in Treating Patients With Recurrent, Metastatic, or Unresectable Ovarian, Fallopian Tube, or Peritoneal Cancer

NCT00004060

Phase 2 Completed Daiichi Sankyo
Treatment

Summary

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. PURPOSE: Phase II trial to study the effectiveness of DX-8951f in treating patients who have recurrent, metastatic, or unresectable ovarian, fallopian tube, or peritoneal cancer.

Timeline

Start
1999-07
Primary completion
2000-09
Completion
2000-09

Drugs

EvaluationDrugModalityDoseRoute
Subject exatecan Small molecule Intravenous